{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:17:10Z","timestamp":1767921430566,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.nano.2014.05.010","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T17:04:06Z","timestamp":1401901446000},"page":"1637-1647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: Towards non-invasive glaucoma gene therapy"],"prefix":"10.1016","volume":"10","author":[{"given":"Samih","family":"Alqawlaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy M.","family":"Sivak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Torin","family":"Huzil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina V.","family":"Ivanova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John G.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Beazely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Foldvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2014.05.010_bb0005","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.nano.2014.05.010_bb0010","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. The Baltimore Eye Survey","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.nano.2014.05.010_bb0015","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0161-6420(95)31055-X","article-title":"Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey","volume":"102","author":"Tielsch","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nano.2014.05.010_bb0020","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1442-9071.2010.02455.x","article-title":"Vascular risk factors in glaucoma: a review","volume":"39","author":"Yanagi","year":"2011","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.nano.2014.05.010_bb0025","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1167\/iovs.05-0541","article-title":"Factors influencing optic nerve head biomechanics","volume":"46","author":"Sigal","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0030","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1167\/iovs.04-0133","article-title":"Finite element modeling of optic nerve head biomechanics","volume":"45","author":"Sigal","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICU.0b013e32834371d2","article-title":"Gene therapy for glaucoma","volume":"22","author":"Demetriades","year":"2011","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.nano.2014.05.010_bb0040","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.survophthal.2009.04.003","article-title":"Gene therapy targeting glaucoma: where are we?","volume":"54","author":"Liu","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.nano.2014.05.010_bb0045","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drudis.2007.11.002","article-title":"Current and future ophthalmic drug delivery systems. A shift to the posterior segment","volume":"13","author":"Del Amo","year":"2008","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2014.05.010_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1021\/cr800409e","article-title":"Nonviral vectors for gene delivery","volume":"109","author":"Mintzer","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.nano.2014.05.010_bb0055","article-title":"Low molecular weight oligochitosans for non-viral retinal gene therapy","author":"Puras","year":"2012","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.05.010_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejps.2012.11.009","article-title":"Oligochitosan polyplexes as carriers for retinal gene delivery","volume":"48","author":"Puras","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0065","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1016\/j.biomaterials.2008.04.036","article-title":"Progress in developing cationic vectors for non-viral systemic gene therapy against cancer","volume":"29","author":"Morille","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.05.010_bb0070","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.biomaterials.2005.09.036","article-title":"Design of modular non-viral gene therapy vectors","volume":"27","author":"De Laporte","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.05.010_bb0075","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2217\/nnm.10.80","article-title":"Advancing nonviral gene delivery: lipid- and surfactant-based nanoparticle design strategies","volume":"5","author":"Donkuru","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2014.05.010_bb0080","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/sj.gt.3301485","article-title":"In vivo gene delivery into ocular tissues by eye drops of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) (PEO-PPO-PEO) polymeric micelles","volume":"8","author":"Liaw","year":"2001","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2014.05.010_bb0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jgm.1093","article-title":"Eye drop delivery of nano-polymeric micelle formulated genes with cornea-specific promoters","volume":"9","author":"Tong","year":"2007","journal-title":"J Gene Med"},{"key":"10.1016\/j.nano.2014.05.010_bb0090","first-page":"1914","article-title":"Gene transfer with liposomes to the intraocular tissues by different routes of administration","volume":"37","author":"Masuda","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0095","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1006\/bbrc.1996.0326","article-title":"Gene transfer to the retina of rat by liposome eye drops","volume":"219","author":"Matsuo","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2014.05.010_bb0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2014.05.010_bb0105","first-page":"1101","article-title":"Gemini surfactants: a distinct class of self-assembling molecules","volume":"82","author":"Hait","year":"2002","journal-title":"Curr Sci India"},{"key":"10.1016\/j.nano.2014.05.010_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/156652308783688491","article-title":"Gemini surfactants: a new family of building blocks for non-viral gene delivery systems","volume":"8","author":"Wettig","year":"2008","journal-title":"Curr Gene Ther"},{"key":"10.1016\/j.nano.2014.05.010_bb0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jgm.763","article-title":"In vivo cutaneous interferon-gamma gene delivery using novel dicationic (gemini) surfactant-plasmid complexes","volume":"7","author":"Badea","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.nano.2014.05.010_bb0120","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/jgm.1060","article-title":"Structural and transfection properties of amine-substituted gemini surfactant-based nanoparticles","volume":"9","author":"Wettig","year":"2007","journal-title":"J Gene Med"},{"key":"10.1016\/j.nano.2014.05.010_bb0125","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1039\/c2jm15719e","article-title":"Designing pH-sensitive gemini nanoparticles for non-viral gene delivery into keratinocytes","volume":"22","author":"Donkuru","year":"2012","journal-title":"J Mater Chem"},{"key":"10.1016\/j.nano.2014.05.010_bb0130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejpb.2010.04.007","article-title":"Enhanced gene expression in epithelial cells transfected with amino acid-substituted gemini nanoparticles","volume":"75","author":"Yang","year":"2010","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2014.05.010_bb0135","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/gt.2011.159","article-title":"Effect of topical interferon-gamma gene therapy using gemini nanoparticles on pathophysiological markers of cutaneous scleroderma in Tsk\/+mice","volume":"19","author":"Badea","year":"2012","journal-title":"Gene Ther"},{"key":"10.1016\/j.nano.2014.05.010_bb0140","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2217\/nnm.12.69","article-title":"Challenges in neuroprotective nanomedicine development: progress towards noninvasive gene therapy of glaucoma","volume":"7","author":"Alqawlaq","year":"2012","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2014.05.010_bb0145","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1023\/A:1023238530504","article-title":"Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers","volume":"20","author":"Pitkanen","year":"2003","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.05.010_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1477-3155-10-7","article-title":"Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles","volume":"10","author":"Singh","year":"2012","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2014.05.010_bb0155","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1042\/bj20031253","article-title":"Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis","volume":"377","author":"Rejman","year":"2004","journal-title":"Biochem J"},{"key":"10.1016\/j.nano.2014.05.010_bb0160","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1039\/C2FD20110K","article-title":"Physical properties of mixed bilayers containing lamellar and nonlamellar lipids: insights from coarse-grain molecular dynamics simulations","volume":"161","author":"Orsi","year":"2013","journal-title":"Faraday Discuss"},{"key":"10.1016\/j.nano.2014.05.010_bb0165","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1051\/jphys:01985004605076100","article-title":"Lyotropic effects of alkanes and headgroup composition on the l\u03b1-Hii lipid liquid crystal phase transition: hydrocarbon packing versus intrinsic curvature","volume":"46","author":"Kirk","year":"1985","journal-title":"J Phys Fr"},{"key":"10.1016\/j.nano.2014.05.010_bb0170","doi-asserted-by":"crossref","first-page":"3894","DOI":"10.1529\/biophysj.104.048710","article-title":"Molecular view of hexagonal phase formation in phospholipid membranes","volume":"87","author":"Marrink","year":"2004","journal-title":"Biophys J"},{"key":"10.1016\/j.nano.2014.05.010_bb0175","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17458080500411965","article-title":"Structural characterization of novel gemini non-viral DNA delivery systems for cutaneous gene therapy","volume":"1","author":"Foldvari","year":"2006","journal-title":"J Exp Nanosci"},{"key":"10.1016\/j.nano.2014.05.010_bb0180","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0005-2736(89)90099-0","article-title":"Use of a quaternary ammonium detergent in liposome mediated DNA transfection of mouse L-cells","volume":"985","author":"Pinnaduwage","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nano.2014.05.010_bb0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/bbrc.1998.9602","article-title":"Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes","volume":"252","author":"Kawakami","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2014.05.010_bb0190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.chemphyslip.2010.08.001","article-title":"Physicochemical characteristics associated with transfection of cationic cholesterol-based gene delivery vectors in the presence of DOPE","volume":"163","author":"Kearns","year":"2010","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/j.nano.2014.05.010_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jconrel.2010.07.109","article-title":"Effects of charge density and hydrophobicity of poly(amido amine)s for non-viral gene delivery","volume":"148","author":"Piest","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.05.010_bb0200","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1023\/A:1018932714745","article-title":"Comparison of cell proliferation and toxicity assays using two cationic liposomes","volume":"11","author":"Lappalainen","year":"1994","journal-title":"Pharm Res"},{"key":"10.1016\/j.nano.2014.05.010_bb0205","doi-asserted-by":"crossref","first-page":"6533","DOI":"10.1021\/bi9801154","article-title":"A novel tetraester construct that reduces cationic lipid-associated cytotoxicity. Implications for the onset of cytotoxicity","volume":"37","author":"Aberle","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.nano.2014.05.010_bb0210","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2006.04.014","article-title":"Toxicity of cationic lipids and cationic polymers in gene delivery","volume":"114","author":"Lv","year":"2006","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2014.05.010_bb0215","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/026119291103900410","article-title":"In-house validation of the EpiOcular(TM) eye irritation test and its combination with the bovine corneal opacity and permeability test for the assessment of ocular irritation","volume":"39","author":"Kolle","year":"2011","journal-title":"Altern Lab Anim"},{"key":"10.1016\/j.nano.2014.05.010_bb0220","first-page":"220","article-title":"Liposomes in topical drug delivery","volume":"22","author":"Schaeffer","year":"1982","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0225","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"Hamalainen","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0230","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.2174\/138161209788923886","article-title":"Nanocarriers in ocular drug delivery: an update review","volume":"15","author":"Wadhwa","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2014.05.010_bb0235","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1167\/iovs.05-0165","article-title":"Vitreous: a barrier to nonviral ocular gene therapy","volume":"46","author":"Peeters","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2014.05.010_bb0240","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2014.05.010_bb0245","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.addr.2006.07.027","article-title":"Challenges and obstacles of ocular pharmacokinetics and drug delivery","volume":"58","author":"Urtti","year":"2006","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2014.05.010_bb0250","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","article-title":"Ocular drug delivery","volume":"12","author":"Gaudana","year":"2010","journal-title":"AAPS J"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414002238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963414002238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T07:55:40Z","timestamp":1565510140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963414002238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1549963414002238"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2014.05.010","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: Towards non-invasive glaucoma gene therapy","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2014.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}